Allscripts announces third quarter of 2022 results

Go back to Allscripts announces third quarter of 2022 results

Allscripts (MDRX) PT Raised to $21 at Deutsche Bank Following Modest 'Beat'

November 4, 2022 1:23 PM EDT

Deutsche Bank analyst George Hill raised the price target on Allscripts (NASDAQ: MDRX) to $21.00 (from $20.00) while maintaining a Buy rating following Q3 beat.

The analyst commented, "Allscripts reported a modest Q3 earnings, above streets expectations. The company reported an adjusted EPS of... More

Allscripts (MDRX) Tops Q3 EPS by 4c

November 3, 2022 4:41 PM EDT

Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.23, $0.04 better than the analyst estimate of $0.19. Revenue for the quarter came in at $152 million versus the consensus estimate of $152.8 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

... More